Fig. 1From: Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trialKaplan–Meier plots of 28-day survival in patients randomized at low-NED (a) and in the high-NED arms (b)Back to article page